Catalyst Wire Dossier Catalyst Wire Dossier

Cediranib (AZD2171, Recentin)

cediranib · AstraZeneca
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cediranib (AZD2171, Recentin), covering 2012-11-01 to 2012-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™) [Phase 2]

See pricing